Cleveland-Cliffs Inc. vs Ecolab Inc. — Stock Comparison
Q·Score Breakdown
5.2
Bearish
Overall
6.6
Neutral
Quality
Health
Growth
Valuation
Sentiment
CLF
Consistently beats earnings estimates (4/4 quarters).
⚠ currently unprofitable (-6% margin).
ECL
High-quality business with 22% return on equity and 13% profit margins.
⚠ balance sheet warrants attention.
Analyst Consensus
HOLD
Target $10.67 (+1.5%)
9 analysts
BUY
Target $317.48 (+22.3%)
21 analysts
Fundamentals
CLF
ECL
—
Trailing P/E
35.1×
22.7×
Forward P/E
27.1×
-6.4%
Profit Margin
12.8%
-2.9%
Gross Margin
44.4%
-18.6%
ROE
22.4%
6.3%
Revenue Growth
10.0%
—
Earnings Growth
7.8%
1.92
Beta
1.02
—
Price / Book
—
$6.0B
Market Cap
$73.3B
$6 – $17
52-Week Range
$249 – $309
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →